UBS Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

UBS Group’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-792,261	Closed	-$21.5M	–	8721
2015 Q4	$21.5M	Sell	792,261 -75,823	-9%	-$1.95M	0.01%	911
2015 Q3	$19M	Sell	868,084 -5,690	-0.7%	-$145K	0.01%	923
2015 Q2	$24.9M	Buy	873,774 +92,726	+12%	+$2.7M	0.02%	841
2015 Q1	$21.4M	Buy	781,048 +277,384	+55%	+$7.64M	0.01%	911
2014 Q4	$13.3M	Buy	+503,664	New	+$14.7M	0.01%	1284

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group's MR Position: Q1 2016 in Review

UBS Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 792,261 shares — an estimated $21.5M sold.

UBS Group first reported a position in MR in Q4 2014 and held it in 5 quarters. The position peaked at $24.9M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

UBS Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
UBS Group sold 792,261 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $21.5M.
UBS Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2014 and held it in 5 quarters.
UBS Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $24.9M in Q2 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on UBS Group's 13F filing for Q1 2016, filed 12 May 2016.